Parthenon LLC Cuts Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Parthenon LLC reduced its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,709 shares of the company’s stock after selling 122 shares during the quarter. Parthenon LLC’s holdings in GE HealthCare Technologies were worth $290,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Blue Trust Inc. raised its holdings in shares of GE HealthCare Technologies by 9.9% in the third quarter. Blue Trust Inc. now owns 2,334 shares of the company’s stock valued at $219,000 after purchasing an additional 210 shares during the last quarter. Raymond James & Associates increased its stake in GE HealthCare Technologies by 10.4% in the 3rd quarter. Raymond James & Associates now owns 421,356 shares of the company’s stock valued at $39,544,000 after buying an additional 39,654 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of GE HealthCare Technologies by 2.3% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company’s stock worth $2,317,000 after buying an additional 562 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in shares of GE HealthCare Technologies by 42.5% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 13,217 shares of the company’s stock worth $1,240,000 after buying an additional 3,941 shares in the last quarter. Finally, Signaturefd LLC boosted its stake in shares of GE HealthCare Technologies by 4.0% in the 3rd quarter. Signaturefd LLC now owns 4,524 shares of the company’s stock worth $425,000 after buying an additional 174 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 0.2 %

Shares of GEHC stock opened at $92.51 on Thursday. The stock has a market capitalization of $42.31 billion, a price-to-earnings ratio of 21.37, a PEG ratio of 3.05 and a beta of 1.15. The company’s fifty day simple moving average is $84.64 and its two-hundred day simple moving average is $85.72. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.66 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently commented on GEHC. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Citigroup raised their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. One analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.